Posticy
Boost your SEO with Backlinks that are worth it
SR Ranko
Turn scattered startup information into focused action.
SR Booster
Submit your startup to 120+ top directories.

New Owner

Gilead Sciences - Phenex Pharmaceuticals

Gilead Sciences acquires Phenex Pharmaceuticals

Announced: January 06, 2015

Type:           Acquisition
Disposition: Separate Entity
Status:         Complete

Amount:       $ 470,000,000

Acquisition News

Add News

Date Title
Oct 15, 2015 BioSpace - Bay Area Startup Lyra Health Closes 35 Million Series A Round Plans Launch of Employer Facing Mental Health Services Platform for Q1 2016
Bay Area Startup Lyra Health Closes 35 Million Series A Round Plans Launch of Employer Facing Mental Health Services Platform for Q1 2016
Jan 06, 2015 gilead.com - Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases
Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases

Gilead Sciences Other Acquisitions

Add Acquisition

Date Acquired Amount
Aug 28, 2017
Kite Pharma
$ 11,900,000,000
Apr 04, 2016
Nimbus Apollo
Undisclosed amount
May 06, 2015
Epitherapeutics
$ 65,000,000
Feb 08, 2013
YM BioSciences
$ 487,600,000
Nov 21, 2011
Pharmasset
$ 11,000,000,000
View more acquisitions »